Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders
Major depressive disorder remains a leading cause of disability worldwide, and current antidepressants are limited by delayed onset and incomplete response. Building on advances driven by ketamine research, renewed interest has focused on classical serotonergic psychedelics—particularly psilocybin,...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mesut Çetin
2026-03-01
|
| Serie: | Psychiatry and Clinical Psychopharmacology |
| Soggetti: | |
| Accesso online: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/3512 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|